agilon health, inc. (NYSE:AGL) Short Interest Update

agilon health, inc. (NYSE:AGLGet Free Report) was the target of a large growth in short interest in August. As of August 31st, there was short interest totalling 41,150,000 shares, a growth of 6.3% from the August 15th total of 38,700,000 shares. Currently, 13.6% of the shares of the stock are short sold. Based on an average trading volume of 4,570,000 shares, the short-interest ratio is currently 9.0 days.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Benchmark restated a “buy” rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Evercore ISI upped their price target on shares of agilon health from $5.50 to $7.00 and gave the company an “in-line” rating in a report on Tuesday, July 9th. Baird R W raised shares of agilon health to a “hold” rating in a research note on Thursday, May 30th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $8.57.

Get Our Latest Stock Report on agilon health

agilon health Stock Up 9.9 %

NYSE AGL traded up $0.36 during trading on Wednesday, reaching $4.00. 4,948,842 shares of the company’s stock traded hands, compared to its average volume of 4,989,289. The company’s 50 day simple moving average is $5.26 and its two-hundred day simple moving average is $5.55. agilon health has a 12-month low of $3.07 and a 12-month high of $20.37. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -5.71 and a beta of 0.54. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting analysts’ consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm posted ($0.04) earnings per share. agilon health’s revenue for the quarter was up 38.7% compared to the same quarter last year. As a group, sell-side analysts forecast that agilon health will post -0.32 EPS for the current fiscal year.

Insider Transactions at agilon health

In other agilon health news, CEO Steven Sell bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Victory Capital Management Inc. boosted its holdings in shares of agilon health by 22.7% in the 4th quarter. Victory Capital Management Inc. now owns 40,466 shares of the company’s stock valued at $508,000 after buying an additional 7,490 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in agilon health by 2.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,846,642 shares of the company’s stock worth $23,175,000 after purchasing an additional 49,758 shares during the last quarter. Norges Bank acquired a new position in shares of agilon health during the fourth quarter worth $27,902,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of agilon health during the 4th quarter valued at $526,000. Finally, Quest Partners LLC acquired a new stake in shares of agilon health in the 4th quarter worth $45,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.